An 2 Therapeutics Inc (ANTX)

Finanzdaten der An 2 Therapeutics Inc-Aktie (ANTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	15.61%8.90	10.55	9.32	10.04	7.22
Research and Development	10.74%6.02	6.74	6.88	7.00	3.20
Operating Income/Loss	15.61%-8.90	-10.55	-9.32	-10.04	-7.22
	18.38%-8.19	-10.03	-8.71	-9.35	-6.46
Attributable To Parent	18.38%-8.19	-10.03	-8.67	-9.35	-6.46
Available To Common Stockholders, Basic	18.38%-8.19	-10.03	-8.71	-9.35	-6.46
Basic Average Shares	31.42%44.76	34.06	-	30.28	30.17
Diluted Average Shares	31.42%44.76	34.06	-	30.28	30.17
Basic Earnings Per Share	37.93%-0.18	-0.29	-	-0.31	-0.21
Diluted Earnings Per Share	37.93%-0.18	-0.29	-	-0.31	-0.21